Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerd Mikus

Showing results (71-80 of 194) with videos related to

Pageof 20
Sort By:
BMJ Paediatrics Open|January 31, 2023
Pharmacokinetics of a microdosed cocktail of three direct oral anticoagulants in children with congenital heart defects: study protocol for a single-centre clinical trial (DOAC-Child)Simon A Hermann, Gerd Mikus, Kristine Chobanyan-Jürgens, et al.
British Journal of Clinical Pharmacology|September 18, 2004
Association of the CYP3A5 A6986G (CYP3A5*3) polymorphism with saquinavir pharmacokineticsMargit Fröhlich, Michael M Hoffmann, Jürgen Burhenne, et al.
Basic & Clinical Pharmacology & Toxicology|March 28, 2019
Decreased Cytochrome P450 3A activity in palliative patients with haematological diseases: Potential impact on supportive drug therapiesMarcus J P Geist, Nelly Siller, Gerlinde Egerer, et al.
Clinical and Translational Science|August 17, 2024
Dose-dependent induction of CYP3A activity by St. John's wort alone and in combination with rifampinNicolas Hohmann, Anna S Friedrichs, Jürgen Burhenne, et al.
Journal of Pharmaceutical Sciences|March 24, 2020
New Insights Into the Pharmacokinetics of Vancomycin After Oral and Intravenous Administration: An Investigation in Beagle DogsMax Sauter, Philipp Uhl, Andreas D Meid, et al.
Journal of Clinical Pharmacology|November 25, 2020
Application of Microdosed Intravenous Omeprazole to Determine Hepatic CYP2C19 ActivityMazyar Mahmoudi, Kathrin I Foerster, Jürgen Burhenne, et al.
Therapeutic Drug Monitoring|June 17, 2006
Comparative bioavailability of the microemulsion formulation of cyclosporine (Neoral) with a generic dispersion formulation (Cicloral) in young healthy male volunteersFrieder Kees, Michael Bucher, Frank Schweda, et al.
European Journal of Clinical Pharmacology|July 11, 2006
Cardiovascular effects of (R)- and (S)-verapamil and racemic verapamil in humans: a placebo-controlled studyDagmar Busse, Silke Templin, Gerd Mikus, et al.
Clinical Pharmacokinetics|March 5, 2019
Microdosed Cocktail of Three Oral Factor Xa Inhibitors to Evaluate Drug-Drug Interactions with Potential Perpetrator DrugsGerd Mikus, Kathrin I Foerster, Marlene Schaumaeker, et al.
Journal of Clinical Pharmacology|December 15, 2010
Daily honey consumption does not change CYP3A activity in humansLeonie Fetzner, Jürgen Burhenne, Johanna Weiss, et al.
Pageof 20

Showing results (71-80 of 194) with videos related to

Sort By:
Pageof 20
BMJ Paediatrics Open|January 31, 2023
Pharmacokinetics of a microdosed cocktail of three direct oral anticoagulants in children with congenital heart defects: study protocol for a single-centre clinical trial (DOAC-Child)Simon A Hermann, Gerd Mikus, Kristine Chobanyan-Jürgens, et al.
British Journal of Clinical Pharmacology|September 18, 2004
Association of the CYP3A5 A6986G (CYP3A5*3) polymorphism with saquinavir pharmacokineticsMargit Fröhlich, Michael M Hoffmann, Jürgen Burhenne, et al.
Basic & Clinical Pharmacology & Toxicology|March 28, 2019
Decreased Cytochrome P450 3A activity in palliative patients with haematological diseases: Potential impact on supportive drug therapiesMarcus J P Geist, Nelly Siller, Gerlinde Egerer, et al.
Clinical and Translational Science|August 17, 2024
Dose-dependent induction of CYP3A activity by St. John's wort alone and in combination with rifampinNicolas Hohmann, Anna S Friedrichs, Jürgen Burhenne, et al.
Journal of Pharmaceutical Sciences|March 24, 2020
New Insights Into the Pharmacokinetics of Vancomycin After Oral and Intravenous Administration: An Investigation in Beagle DogsMax Sauter, Philipp Uhl, Andreas D Meid, et al.
Journal of Clinical Pharmacology|November 25, 2020
Application of Microdosed Intravenous Omeprazole to Determine Hepatic CYP2C19 ActivityMazyar Mahmoudi, Kathrin I Foerster, Jürgen Burhenne, et al.
Therapeutic Drug Monitoring|June 17, 2006
Comparative bioavailability of the microemulsion formulation of cyclosporine (Neoral) with a generic dispersion formulation (Cicloral) in young healthy male volunteersFrieder Kees, Michael Bucher, Frank Schweda, et al.
European Journal of Clinical Pharmacology|July 11, 2006
Cardiovascular effects of (R)- and (S)-verapamil and racemic verapamil in humans: a placebo-controlled studyDagmar Busse, Silke Templin, Gerd Mikus, et al.
Clinical Pharmacokinetics|March 5, 2019
Microdosed Cocktail of Three Oral Factor Xa Inhibitors to Evaluate Drug-Drug Interactions with Potential Perpetrator DrugsGerd Mikus, Kathrin I Foerster, Marlene Schaumaeker, et al.
Journal of Clinical Pharmacology|December 15, 2010
Daily honey consumption does not change CYP3A activity in humansLeonie Fetzner, Jürgen Burhenne, Johanna Weiss, et al.
Pageof 20